Systemic sclerosis (SSc) is a connective tissue disease clinically characterized by different degrees of skin fibrosis and visceral organ involvement Joint involvement with severe synovitis during SSc is relatively uncommon. About 11% of SSc patients present with arthritis at disease onset , usually characterized by mono-oligoarthritis, responsive to steroid therapy.
Successful treatment with leflunomide of arthritis in systemic sclerosis patients / Sebastiani, Marco; Giuggioli, D; Vesprini, E; Caruso, A; Ferri, Clodoveo. - In: RHEUMATOLOGY. - ISSN 1462-0324. - STAMPA. - 45:9(2006), pp. 1175-1176. [10.1093/rheumatology/kei248]
Successful treatment with leflunomide of arthritis in systemic sclerosis patients
SEBASTIANI, Marco;Giuggioli D;FERRI, Clodoveo
2006
Abstract
Systemic sclerosis (SSc) is a connective tissue disease clinically characterized by different degrees of skin fibrosis and visceral organ involvement Joint involvement with severe synovitis during SSc is relatively uncommon. About 11% of SSc patients present with arthritis at disease onset , usually characterized by mono-oligoarthritis, responsive to steroid therapy.File | Dimensione | Formato | |
---|---|---|---|
Successful treatment with leflunomide of arthritis in systemic sclerosis patients.pdf
Solo gestori archivio
Tipologia:
Versione pubblicata dall'editore
Dimensione
71.54 kB
Formato
Adobe PDF
|
71.54 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris